Endurant Capital Management’s Ocular Therapeutix OCUL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
|
|||||
|
2023
Q3 | $1.11M | Sell |
|
|||||
|
2023
Q2 | $1.9M | Sell |
|
|||||
|
2023
Q1 | $2.7M | Sell |
|
|||||
|
2022
Q4 | $2.99M | Sell |
|
|||||
|
2022
Q3 | $4.42M | Buy |
|
|||||
|
2022
Q2 | $3.06M | Sell |
|
|||||
|
2022
Q1 | $4.57M | Buy |
|
|||||
|
2021
Q4 | $5M | Buy |
|
|||||
|
2021
Q3 | $6.1M | Buy |
|
|||||
|
2021
Q2 | $8.1M | Buy |
|
|||||
|
2021
Q1 | $7.2M | Buy |
|
|||||
|
2020
Q4 | $6.01M | Sell |
|
|||||
|
2020
Q3 | $6.37M | Buy |
|
|||||
|
2020
Q2 | $6.29M | Buy |
|
|||||
|
2019
Q2 | – | Sell |
|
|||||
|
2019
Q1 | $2.84M | Buy |
|
|||||
|
2018
Q4 | $926K | Sell |
|
|||||
|
2018
Q3 | $2.08M | Buy |
|
|||||
|
2018
Q2 | $964K | Sell |
|
|||||
|
2018
Q1 | $1.16M | Buy |
|